PB-101

N/A

Report date: 2023/10/13 20:08:36

Base Information

Drug NamePB-101
Drug Alias NamePB-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor B inhibitorsPlacental Growth Factor inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor BVascular endothelial growth factor APlacental Growth Factor
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPanolos Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesPanolos Bioscience IncPrecision Biotech Taiwan Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A